Volume 62, Issue 4

Semiparametric regression for the mean and rate functions of recurrent events

D. Y. Lin

University of Washington, Seattle, USA,

Search for more papers by this author
L. J. Wei

Harvard University, Boston, USA,

Search for more papers by this author
I. Yang

Schering‐Plough Research Institute, Kenilworth, USA,

Search for more papers by this author
Z. Ying

Rutgers University, Piscataway, USA

Search for more papers by this author
First published: 06 January 2002
Citations: 392
D. Y. Lin Department of Biostatistics, School of Public Health and Community Medicine, University of Washington, Box 357232, Seattle, WA 98195‐7232, USAE-mail address: danyu@biostat.washington.edu

Abstract

The counting process with the Cox‐type intensity function has been commonly used to analyse recurrent event data. This model essentially assumes that the underlying counting process is a time‐transformed Poisson process and that the covariates have multiplicative effects on the mean and rate function of the counting process. Recently, Pepe and Cai, and Lawless and co‐workers have proposed semiparametric procedures for making inferences about the mean and rate function of the counting process without the Poisson‐type assumption. In this paper, we provide a rigorous justification of such robust procedures through modern empirical process theory. Furthermore, we present an approach to constructing simultaneous confidence bands for the mean function and describe a class of graphical and numerical techniques for checking the adequacy of the fitted mean–rate model. The advantages of the robust procedures are demonstrated through simulation studies. An illustration with multiple‐infection data taken from a clinical study on chronic granulomatous disease is also provided.

Number of times cited according to CrossRef: 392

  • Effect of Sacubitril/Valsartan on Biomarkers of Extracellular Matrix Regulation in Patients With HFpEF, Journal of the American College of Cardiology, 10.1016/j.jacc.2020.05.072, 76, 5, (503-514), (2020).
  • Peritoneal Dialysis–Related Infection Rates and Outcomes: Results From the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS), American Journal of Kidney Diseases, 10.1053/j.ajkd.2019.09.016, (2020).
  • Prior Heart Failure Hospitalization, Clinical Outcomes, and Response to Sacubitril/Valsartan Compared With Valsartan in HFpEF, Journal of the American College of Cardiology, 10.1016/j.jacc.2019.11.003, 75, 3, (245-254), (2020).
  • Prospective assessment of loss to follow‐up: incidence and associated factors in a cohort of HIV‐positive adults in rural Tanzania, Journal of the International AIDS Society, 10.1002/jia2.25460, 23, 3, (2020).
  • Measuring Player Retention and Monetization Using the Mean Cumulative Function, IEEE Transactions on Games, 10.1109/TG.2020.2964120, 12, 1, (101-114), (2020).
  • Effects of Sacubitril/Valsartan on N-Terminal Pro-B-Type Natriuretic Peptide in Heart Failure With Preserved Ejection Fraction, JACC: Heart Failure, 10.1016/j.jchf.2020.03.002, (2020).
  • Doubly robust estimation and causal inference for recurrent event data, Statistics in Medicine, 10.1002/sim.8541, 39, 17, (2324-2338), (2020).
  • Myocardial Infarction in Heart Failure With Preserved Ejection Fraction, JACC: Heart Failure, 10.1016/j.jchf.2020.02.007, (2020).
  • Asymmetric information in secondary insurance markets: Evidence from the life settlements market, Quantitative Economics, 10.3982/QE1333, 11, 3, (1143-1175), (2020).
  • A Generalized Model for Recurrent Failures Prediction, Reliability Engineering & System Safety, 10.1016/j.ress.2020.107125, (107125), (2020).
  • Effect of Dapagliflozin on Outpatient Worsening of Patients with Heart Failure and Reduced Ejection Fraction: A Prespecified Analysis of DAPA-HF, Circulation, 10.1161/CIRCULATIONAHA.120.047480, (2020).
  • Estimation on conditional restricted mean survival time with counting process, Journal of Biopharmaceutical Statistics, 10.1080/10543406.2020.1814799, (1), (2020).
  • Efficient Multiple Imputation for Sensitivity Analysis of Recurrent Events Data with Informative Censoring, Statistics in Biopharmaceutical Research, 10.1080/19466315.2020.1819403, (1), (2020).
  • Variable selection in joint frailty models of recurrent and terminal events, Biometrics, 10.1111/biom.13242, 0, 0, (2020).
  • Model-free slice screening for ultrahigh-dimensional survival data, Journal of Applied Statistics, 10.1080/02664763.2020.1772734, (1-20), (2020).
  • Serum uric acid, influence of sacubitril–valsartan, and cardiovascular outcomes in heart failure with preserved ejection fraction: PARAGON‐HF, European Journal of Heart Failure, 10.1002/ejhf.1984, 0, 0, (2020).
  • Semiparametric modelling and estimation of covariate‐adjusted dependence between bivariate recurrent events, Biometrics, 10.1111/biom.13229, 0, 0, (2020).
  • Regression Models and Multivariate Life Tables, Journal of the American Statistical Association, 10.1080/01621459.2020.1713792, (1-16), (2020).
  • Burden of Menstrual Pain Measured by Heatmap Visualization of Daily Patient-Reported Data in Japanese Patients Treated with Ethinylestradiol/Drospirenone: A Randomized Controlled Study

    ,
    International Journal of Women's Health, 10.2147/IJWH.S242864, Volume 12, (175-185), (2020).
  • A joint modeling approach for analyzing marker data in the presence of a terminal event, Biometrics, 10.1111/biom.13260, 0, 0, (2020).
  • Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes, JAMA, 10.1001/jama.2020.1906, (2020).
  • A flexible additive-multiplicative transformation mean model for recurrent event data, Communications in Statistics - Theory and Methods, 10.1080/03610926.2020.1748654, (1-12), (2020).
  • A partial likelihood-based two-dimensional multistate markov model with application to myocardial infarction and stroke recurrence, Sankhya B, 10.1007/s13571-019-00212-y, (2020).
  • Analysis of recurrent hypoglycemic events, Journal of Biopharmaceutical Statistics, 10.1080/10543406.2020.1765370, (1-9), (2020).
  • Causal inference for recurrent event data using pseudo-observations, Biostatistics, 10.1093/biostatistics/kxaa020, (2020).
  • Statistical analysis of clustered mixed recurrent-event data with application to a cancer survivor study, Lifetime Data Analysis, 10.1007/s10985-020-09500-6, (2020).
  • Comparative Methodological Assessment of the Randomized GLOBAL LEADERS Trial Using Total Ischemic and Bleeding Events, Circulation: Cardiovascular Quality and Outcomes, 10.1161/CIRCOUTCOMES.120.006660, (2020).
  • Recurrent Events Analysis With Data Collected at Informative Clinical Visits in Electronic Health Records, Journal of the American Statistical Association, 10.1080/01621459.2020.1801447, (1-479), (2020).
  • Event history analysis of dynamic networks, Biometrika, 10.1093/biomet/asaa045, (2020).
  • School performance, psychiatric comorbidity, and healthcare utilization in pediatric multiple sclerosis: A nationwide population-based observational study, Multiple Sclerosis Journal, 10.1177/1352458520959673, (135245852095967), (2020).
  • Analysis of cyclic recurrent event data with multiple event types, Japanese Journal of Statistics and Data Science, 10.1007/s42081-020-00088-7, (2020).
  • Analyzing wearable device data using marked point processes, Biometrics, 10.1111/biom.13269, 0, 0, (2020).
  • Efficacy of Dapagliflozin on Renal Function and Outcomes in Patients with Heart Failure with Reduced Ejection Fraction: Results of DAPA-HF, Circulation, 10.1161/CIRCULATIONAHA.120.050391, (2020).
  • Intravenous Iron Dosing and Infection Risk in Patients on Hemodialysis: A Prespecified Secondary Analysis of the PIVOTAL Trial, Journal of the American Society of Nephrology, 10.1681/ASN.2019090972, (ASN.2019090972), (2020).
  • Joint analysis of recurrence and termination: A Bayesian latent class approach, Statistical Methods in Medical Research, 10.1177/0962280220962522, (096228022096252), (2020).
  • Regression analysis of recurrent‐event‐free time from multiple follow‐up windows, Statistics in Medicine, 10.1002/sim.8385, 39, 1, (1-15), (2019).
  • Penalized survival models for the analysis of alternating recurrent event data, Biometrics, 10.1111/biom.13153, 76, 2, (448-459), (2019).
  • Semiparametric multiparameter regression survival modeling, Scandinavian Journal of Statistics, 10.1111/sjos.12416, 47, 2, (555-571), (2019).
  • Residential eviction predicts initiation of or relapse into crystal methamphetamine use among people who inject drugs: a prospective cohort study, Journal of Public Health, 10.1093/pubmed/fdx187, 41, 1, (36-45), (2019).
  • Simultaneous estimation and variable selection for incomplete event history studies, Journal of Multivariate Analysis, 10.1016/j.jmva.2019.01.005, (2019).
  • A general class of additive semiparametric models for recurrent event data, Journal of Statistical Planning and Inference, 10.1016/j.jspi.2019.07.006, (2019).
  • Semiparametric Inference for Proportional Mean Past Life Model, The International Journal of Biostatistics, 10.1515/ijb-2018-0020, 0, 0, (2019).
  • Effects of Icosapent Ethyl on Total Ischemic Events: From REDUCE-IT, Journal of the American College of Cardiology, 10.1016/j.jacc.2019.02.032, (2019).
  • On a General Class of Semiparametric Hazards Regression Models for Recurrent Gap Times, Acta Mathematicae Applicatae Sinica, English Series, 10.1007/s10255-019-0831-9, 35, 3, (549-563), (2019).
  • On estimands arising from misspecified semiparametric rate‐based analysis of recurrent episodic conditions, Statistics in Medicine, 10.1002/sim.8345, 38, 25, (4977-4998), (2019).
  • Marginal hazard ratio estimates in joint frailty models for heart failure trials, Biometrical Journal, 10.1002/bimj.201800133, 61, 6, (1385-1401), (2019).
  • Nonparametric group sequential methods for recurrent and terminal events from multiple follow‐up windows, Statistics in Medicine, 10.1002/sim.8389, 38, 30, (5657-5669), (2019).
  • Echocardiographic Features of Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction, Journal of the American College of Cardiology, 10.1016/j.jacc.2019.09.063, 74, 23, (2858-2873), (2019).
  • Dynamic regression with recurrent events, Biometrics, 10.1111/biom.13105, 75, 4, (1264-1275), (2019).
  • An Additive-Multiplicative Cox-Aalen Subdistribution Hazard Model for Competing Risks Data, Journal of Systems Science and Complexity, 10.1007/s11424-019-7281-6, 32, 6, (1727-1746), (2019).
  • Group variable selection in the Andersen-Gill model for recurrent event data, Journal of Statistical Planning and Inference, 10.1016/j.jspi.2019.11.005, (2019).
  • Survival analysis of Rural Clinical School of Western Australia graduates: the long-term work of building a long-term rural medical workforce, BMC Health Services Research, 10.1186/s12913-019-4816-4, 19, 1, (2019).
  • INTERMITTENT INTENSIVE INSULIN THERAPY FOR TYPE 2 DIABETES: EFFECTS ON HYPOGLYCEMIA, WEIGHT GAIN, AND QUALITY OF LIFE OVER 2 YEARS, Endocrine Practice, 10.4158/EP-2019-0111, 25, 9, (899-907), (2019).
  • Modeling marginal features in studies of recurrent events in the presence of a terminal event, Lifetime Data Analysis, 10.1007/s10985-019-09462-4, (2019).
  • Multiplicative rates model for recurrent events in case-cohort studies, Lifetime Data Analysis, 10.1007/s10985-019-09466-0, (2019).
  • Effects of Early Frequent Nephrology Care on Emergency Department Visits among Patients with End-stage Renal Disease, International Journal of Environmental Research and Public Health, 10.3390/ijerph16071158, 16, 7, (1158), (2019).
  • Automation of network monitoring: methodology of destructive risk assessment, IOP Conference Series: Materials Science and Engineering, 10.1088/1757-899X/537/5/052022, 537, (052022), (2019).
  • Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction, New England Journal of Medicine, 10.1056/NEJMoa1908655, (2019).
  • Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction, New England Journal of Medicine, 10.1056/NEJMoa1911303, (2019).
  • Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction, New England Journal of Medicine, 10.1056/NEJMoa1912388, (2019).
  • Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to Age: Insights From DAPA-HF, Circulation, 10.1161/CIRCULATIONAHA.119.044133, (2019).
  • Lactobacillus pentosus Modulates Immune Response by Inducing IL-10 Producing Tr1 Cells , Immune Network, 10.4110/in.2019.19.e39, 19, 6, (2019).
  • Prenatal Exposure to Lead and Chromium is Associated with IL-13 Levels in Umbilical Cord Blood and Severity of Atopic Dermatitis: COCOA Study, Immune Network, 10.4110/in.2019.19.e42, 19, 6, (2019).
  • A semiparametric additive rates model for the weighted composite endpoint of recurrent and terminal events, Lifetime Data Analysis, 10.1007/s10985-019-09486-w, (2019).
  • Semiparametric mean model with non linear time effect of the covariate for clustered recurrent events with terminal events, Communications in Statistics - Theory and Methods, 10.1080/03610926.2019.1674872, (1-19), (2019).
  • Partial sufficient dimension reduction on joint model of recurrent and terminal events, Journal of Applied Statistics, 10.1080/02664763.2018.1506019, 46, 3, (522-541), (2018).
  • The wild bootstrap for multivariate Nelson–Aalen estimators, Lifetime Data Analysis, 10.1007/s10985-018-9423-x, 25, 1, (97-127), (2018).
  • Semiparametric temporal process regression of survival-out-of-hospital, Lifetime Data Analysis, 10.1007/s10985-018-9433-8, 25, 2, (322-340), (2018).
  • Commentary on Tayob and Murray (2014) with a useful update pertaining to study design, Biostatistics, 10.1093/biostatistics/kxy051, 20, 3, (542-545), (2018).
  • The effect of omitted covariates in marginal and partially conditional recurrent event analyses, Lifetime Data Analysis, 10.1007/s10985-018-9430-y, 25, 2, (280-300), (2018).
  • Assessing Treatment Effects That Capture Disease Burden in Serious Chronic Diseases, Therapeutic Innovation & Regulatory Science, 10.1177/2168479018784912, 53, 3, (387-397), (2018).
  • Group sequential designs with robust semiparametric recurrent event models, Statistical Methods in Medical Research, 10.1177/0962280218780538, 28, 8, (2385-2403), (2018).
  • Association of Cardiac Rehabilitation With Decreased Hospitalizations and Mortality After Ventricular Assist Device Implantation, JACC: Heart Failure, 10.1016/j.jchf.2017.11.002, 6, 2, (130-139), (2018).
  • A Joint Modeling Approach for Longitudinal Data with Informative Observation Times and a Terminal Event, Statistics in Biosciences, 10.1007/s12561-018-9221-8, 10, 3, (609-633), (2018).
  • Shortening the washout to 4 weeks when switching from natalizumab to fingolimod and risk of disease reactivation in multiple sclerosis, Multiple Sclerosis and Related Disorders, 10.1016/j.msard.2018.07.005, 25, (14-20), (2018).
  • A novel approach for analyzing data on recurrent events with duration to estimate the combined cumulative rate of both variables over time, Contemporary Clinical Trials Communications, 10.1016/j.conctc.2018.03.002, 10, (50-56), (2018).
  • Joint analysis of recurrent event data with additive–multiplicative hazards model for the terminal event time, Metrika, 10.1007/s00184-018-0654-3, 81, 5, (523-547), (2018).
  • Semiparametric analysis of the additive hazards model with informatively interval-censored failure time data, Computational Statistics & Data Analysis, 10.1016/j.csda.2018.03.011, 125, (1-9), (2018).
  • Cardiac rehabilitation and readmissions after heart transplantation, The Journal of Heart and Lung Transplantation, 10.1016/j.healun.2017.05.017, 37, 4, (467-476), (2018).
  • Effect of Basal Insulin Glargine on First and Recurrent Episodes of Heart Failure Hospitalization, Circulation, 10.1161/CIRCULATIONAHA.117.030924, 137, 1, (88-90), (2018).
  • Comparison of Time-to-First Event and Recurrent-Event Methods in Randomized Clinical Trials, Circulation, 10.1161/CIRCULATIONAHA.117.033065, 138, 6, (570-577), (2018).
  • Disease-modifying drugs for multiple sclerosis and infection risk: a cohort study, Journal of Neurology, Neurosurgery & Psychiatry, 10.1136/jnnp-2017-317493, 89, 10, (1050-1056), (2018).
  • A Phase 3 Trial of l -Glutamine in Sickle Cell Disease , New England Journal of Medicine, 10.1056/NEJMoa1715971, 379, 3, (226-235), (2018).
  • Randomized phase 2 trial of monthly vitamin D to prevent respiratory complications in children with sickle cell disease, Blood Advances, 10.1182/bloodadvances.2017013979, 2, 9, (969-978), (2018).
  • An embedded estimating equation for the additive risk model with biased-sampling data, Science China Mathematics, 10.1007/s11425-017-9268-0, 61, 8, (1495-1518), (2018).
  • Commentary: Alignment of time scales and joint models, Lifetime Data Analysis, 10.1007/s10985-018-9446-3, 24, 4, (601-604), (2018).
  • An Additive Hazards Model for Clustered Recurrent Gap Times, Journal of Systems Science and Complexity, 10.1007/s11424-018-6329-3, 31, 5, (1377-1390), (2018).
  • Generalized accelerated recurrence time model for multivariate recurrent event data with missing event type, Biometrics, 10.1111/biom.12847, 74, 3, (954-965), (2018).
  • Inference on semiparametric transformation model with general interval-censored failure time data, Journal of Nonparametric Statistics, 10.1080/10485252.2018.1478091, 30, 3, (758-773), (2018).
  • Non-fatal repetition of self-harm in Taipei City, Taiwan: cohort study, British Journal of Psychiatry, 10.1192/bjp.bp.113.130179, 204, 5, (376-382), (2018).
  • Intravenous Iron in Patients Undergoing Maintenance Hemodialysis, New England Journal of Medicine, 10.1056/NEJMoa1810742, (2018).
  • Robust estimation for panel count data with informative observation times and censoring times, Lifetime Data Analysis, 10.1007/s10985-018-09457-7, (2018).
  • Excess risk estimation for matched cohort survival data, Statistical Methods in Medical Research, 10.1177/0962280218804269, (096228021880426), (2018).
  • Statistical inference for the accelerated failure time model under two-stage generalized case–cohort design, Communications in Statistics - Theory and Methods, 10.1080/03610926.2018.1528363, (1-17), (2018).
  • Statistical inference for generalized case-cohort design under the proportional hazards model with parameter constraints, Communications in Statistics - Simulation and Computation, 10.1080/03610918.2018.1458128, (1-20), (2018).
  • A pragmatic randomised controlled trial and economic evaluation of family therapy versus treatment as usual for young people seen after second or subsequent episodes of self-harm: the Self-Harm Intervention – Family Therapy (SHIFT) trial, Health Technology Assessment, 10.3310/hta22120, 22, 12, (1-222), (2018).
  • Covariate-Adjusted Regression for Distorted Longitudinal Data With Informative Observation Times, Journal of the American Statistical Association, 10.1080/01621459.2018.1482757, (1-10), (2018).
  • An additive marginal regression model for clustered recurrent event in the presence of a terminal event, Communications in Statistics - Theory and Methods, 10.1080/03610926.2017.1332221, 47, 8, (1901-1912), (2017).
  • A semiparametric additive rate model for a modulated renewal process, Lifetime Data Analysis, 10.1007/s10985-017-9413-4, 24, 4, (675-698), (2017).
  • Sources of Safety Data and Statistical Strategies for Design and Analysis, Therapeutic Innovation & Regulatory Science, 10.1177/2168479017738980, 52, 2, (141-158), (2017).
  • See more